Filter
1803
Filtered Results: 1803
Text search:
pharmaceutical
needs
Featured
Recommendations
163
New Publications
506
Language
Document type
No document type
969
Studies & Reports
327
Guidelines
258
Manuals
89
Strategic & Response Plan
86
Fact sheets
23
Training Material
22
Situation Updates
14
Resource Platforms
5
Infographics
5
Brochures
3
Online Courses
2
Countries / Regions
India
79
Kenya
71
Ethiopia
69
Global
68
South Africa
50
Western and Central Europe
44
Nigeria
42
Uganda
40
Liberia
36
Sierra Leone
34
Namibia
25
Nepal
24
Zambia
24
Tanzania
24
Rwanda
24
Bangladesh
23
Malawi
23
Ukraine
23
Ghana
22
Africa
22
Syria
19
Eastern Europe
19
Zimbabwe
17
Philippines
17
Cambodia
16
Lesotho
15
South–East Asia Region
14
Latin America and the Carribbean
14
Indonesia
12
Myanmar / Burma
11
Eswatini/ Swaziland
10
West and Central Africa
9
South Sudan
8
Botswana
8
East and Southern Africa
8
Eastern Europe and Central Asia
8
Congo, Democratic Republic of
7
Cameroon
7
Germany
7
Asia
7
Venezuela
7
Senegal
6
Haiti
6
Guinea
5
Burkina Faso
5
Pakistan
5
Middle East and North Africa
5
Western Pacific Region
5
Papua New Guinea
4
Vietnam
4
Mali
3
USA
3
Jordan
3
Afghanistan
3
Lebanon
3
Egypt
3
Thailand
3
Mozambique
3
Brazil
3
North Macedonia
3
Albania
3
Laos
3
Russia
3
North America
3
United Kingdom
3
Iraq
2
China
2
Sudan
2
Benin
2
Central African Republic
2
Peru
2
Serbia
2
Yemen
2
Fiji
2
Southern Africa
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Chad
1
Malaysia
1
Ireland
1
El Salvador
1
Libya
1
Sri Lanka
1
Bhutan
1
Palestine
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
749
Clinical Guidelines
117
Public Health
100
Key Resources
70
Women & Child Health
46
Pharmacy & Technologies
25
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
158
Pharmacy
154
COVID-19
136
Mental Health
107
HIV
100
TB
85
Rapid Response
56
NCDs
42
Planetary Health
40
Caregiver
39
NTDs
38
Global Health Education
35
Conflict
34
Ebola
30
Health Financing Toolbox
26
Disability
15
Refugee
14
Specific Hazards
12
Polio
11
Natural Hazards
9
Cholera
4
Zika
3
Social Ethics
3
Health Financing
2
South Sudan
1
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
Reporting period January 2015 – December 2015
Bucharest, April 2016
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order ...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
NAMI HelpLine
Contents
I’m having a lot of anxiety because of the coronavirus. Please help.
I’m quarantined or working from home – lonely and isolated even further – what can I do?
I don’t have health insurance or a regular doctor – how can I get care?
What if I’m quarantin...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
This document is a guide for national authorities who are responsible for managing public health responses to COVID-19
This strategy, produced by IFRC, UNICEF and WHO, provides an overview of RCCE coordination approach and priorities across the different phases of the COVID-19 preparedness and response
The “United Nations Framework for the immediate socio-economic response to COVID-19: Shared responsibility, global solidarity and urgent action for people in need” calls for protecting jobs, businesses and livelihoods to set in motion a safe recovery of societies and economies as soon as possibl...
